Belgium vs Malta: Prevalence of current tobacco use, males
Prevalence of current tobacco use, males over time
- Belgium
- Malta
How they compare
Belgium currently reports 26.4% against 26.0% in Malta, a difference of 0.4%.
The two have swapped places 1 time across 9 shared years of data; in 2000 it was Malta ahead.
Belgium ranks 85th and Malta ranks 87th of 166 countries.
Across the 3 decades both report, Belgium averaged higher in 1 and Malta in 2.
Head to head by decade
| Decade | Belgium | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 34.3% | 37.7% | 3.5% | Malta |
| 2010s | 30.8% | 32.2% | 1.5% | Malta |
| 2020s | 27.1% | 26.9% | 0.2% | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of current tobacco use, males, Belgium or Malta?
- Belgium, at 26.4% against 26.0% in Malta as of 2024.
- What is the difference in prevalence of current tobacco use, males between Belgium and Malta?
- 0.4%, with Belgium ahead.
- How many years of comparable data are there for Belgium and Malta?
- 9 years are reported by both, from 2000 to 2024.
- How do Belgium and Malta rank globally for prevalence of current tobacco use, males?
- Belgium ranks 85th and Malta ranks 87th of 166 countries.
- Where does this data come from?
- Global Health Observatory Data Repository, World Health Organization (WHO), published as Prevalence of current tobacco use, males (% of male adults). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of the male population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.